BioCentury
ARTICLE | Clinical News

Alteon preclinical data

September 25, 2006 7:00 AM UTC

In a mouse model of diabetic nephropathy, alagebrium protected against advanced glycosylation end-product (A.G.E.) mediated effects on the kidney. Alagebrium, a A.G.E crosslink breaker reduced serum,...